Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-08-000011

Chairman/CEO/CFO bought 7,850 shares at an average $0.34 ($2,634)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Chairman/CEO/CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2008-07-25 Purchase : show line 1 in the form +5,000 $0.35 $1,750 2,072,100 I
2008-07-28 Purchase : show line 2 in the form +2,850 $0.31 $884 2,074,950 I
Open-market purchases · 7,850 sh · avg $0.34 · $2,634
Loading xslF345X03/primary_doc.xml…